Matches in Nanopublications for { ?s ?p "[In logistic regression analysis before and after adjustment for other factors known to affect this condition (age, body mass index, sulfonylurea mean daily dose, duration of T2DM, renal function and CYP2C9 genotype) KCNJ11 E23K polymorphism did not affect hypoglycemia risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[In logistic regression analysis before and after adjustment for other factors known to affect this condition (age, body mass index, sulfonylurea mean daily dose, duration of T2DM, renal function and CYP2C9 genotype) KCNJ11 E23K polymorphism did not affect hypoglycemia risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP341936.RAcsj5kFSa7NUHtjY4l7ly3B69RAs9PfQMA1Ya_pTYknw130_assertion description "[In logistic regression analysis before and after adjustment for other factors known to affect this condition (age, body mass index, sulfonylurea mean daily dose, duration of T2DM, renal function and CYP2C9 genotype) KCNJ11 E23K polymorphism did not affect hypoglycemia risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341936.RAcsj5kFSa7NUHtjY4l7ly3B69RAs9PfQMA1Ya_pTYknw130_provenance.
- NP931992.RA1Ju5vq5DUjuac_deA-B4T_3ya1kri54LJ_9xFznyJ6U130_assertion description "[In logistic regression analysis before and after adjustment for other factors known to affect this condition (age, body mass index, sulfonylurea mean daily dose, duration of T2DM, renal function and CYP2C9 genotype) KCNJ11 E23K polymorphism did not affect hypoglycemia risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931992.RA1Ju5vq5DUjuac_deA-B4T_3ya1kri54LJ_9xFznyJ6U130_provenance.
- NP982779.RAVzg3zVfyFIXxRkPMilhgVyBSIGgf3gv_gTYwLwMjM8Y130_assertion description "[In logistic regression analysis before and after adjustment for other factors known to affect this condition (age, body mass index, sulfonylurea mean daily dose, duration of T2DM, renal function and CYP2C9 genotype) KCNJ11 E23K polymorphism did not affect hypoglycemia risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982779.RAVzg3zVfyFIXxRkPMilhgVyBSIGgf3gv_gTYwLwMjM8Y130_provenance.